Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates

Cancer

Volumn 121, Issue 11, 2015, Pages 1793-1799

  Ho, Allen S ^a   Davies, Louise ^b,c   Nixon, Iain J ^a   Palmer, Frank L ^a   Wang, Laura Y ^a   Patel, Snehal G ^a   Ganly, Ian ^a   Wong, Richard J ^a   Tuttle, R Michael ^a   Morris, Luc G T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b VA MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

incidence; overdiagnosis; overtreatment; survival; thyroid cancer; thyroid cancer mortality

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; HUMAN; PRIORITY JOURNAL; SURVIVAL RATE; THYROID CANCER; TUMOR VOLUME; UNITED STATES; CANCER REGISTRY; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; INCIDENCE; MALE; MORTALITY; PATHOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; THYROID NEOPLASMS;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; SEER PROGRAM; SURVIVAL RATE; THYROID NEOPLASMS; UNITED STATES;

EID: 84929652911     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29289     Document Type: Article

References (30)

1. Esserman LJ, Thompson IM Jr, Reid B,. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013; 310: 797-798.
2. Esserman LJ, Thompson IM, Reid B, et al., Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014; 15: e234-e242.
3. Davies L, Welch HG,. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140: 317-322.
4. Davies L, Welch HG,. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.
5. Lee TJ, Kim S, Cho HJ, Lee JH,. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci. 2012; 27: 1491-1498.
6. Feinstein AR, Sosin DM, Wells CK,. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985; 312: 1604-1608.
7. Nixon IJ, Ganly I, Patel SG, et al., Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg. 2012; 10: 618-623.
8. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Mortality-All COD, Aggregated With State, Total US (1969-2010) . Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013; underlying mortality data provided by National Center for Health Statistics (cdc.gov/nchs).
9. Surveillance Research, National Cancer Institute. Complete Prevalence (ComPrev) Software. Version 2.0. Available at: surveillance.cancer.gov/comprev/. Accessed March 2014.
10. Surveillance Research, National Cancer Institute. Projected Prevalence (ProjPrev) Software. Version 1.0.4. Available at: surveillance.cancer.gov/projprev/. Accessed March 2014.
11. Tiwari RC, Clegg LX, Zou Z,. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006; 15: 547-569.
12. Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen ML, Visser O, Verbeek AL, Kiemeney LA,. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2011; 21: 573-577.
13. Kamangar F, Dores GM, Anderson WF,. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24: 2137-2150.
14. Ito Y, Miyauchi A, Kobayashi K, Miya A,. Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma. Endocr J. 2014; 61: 205-213.
15. Li Y, Tiwari RC, Zou Z,. An age-stratified poisson model for comparing trends in cancer rates across overlapping regions. Biom J. 2008; 50: 608-619.
16. Dickman PW, Sloggett A, Hills M, Hakulinen T,. Regression models for relative survival. Stat Med. 2004; 23: 51-64.
17. Nagar S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Grogan RH,. Hurthle cell carcinoma: an update on survival over the last 35 years. Surgery. 2013; 154: 1263-1271; discussion 1271.
18. Gondos A, Bray F, Hakulinen T, Brenner H,; EUNICE Survival Working Group. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009; 20: 564-573.
19. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS,. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46: 109-123.
20. Tisell LE, Nilsson B, Molne J, et al., Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996; 20: 854-859.
21. Banach R,. Davies and Welch draw unfounded conclusions about thyroid cancer from epidemiological data. JAMA Otolaryngol Head Neck Surg. 2014; 140: 678-679.
22. Black WC, Welch HG,. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328: 1237-1243.
23. Kweon SS, Shin MH, Chung IJ, Kim YJ, Choi JS,. Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol. 2013; 43: 1039-1046.
24. Ahn HS, Kim HJ, Welch HG,. Korea's thyroid-cancer "epidemic"-screening and overdiagnosis. N Engl J Med. 2014; 371: 1765-1767.
25. Davies L, Ouellette M, Hunter M, Welch HG,. The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope. 2010; 120: 2446-2451.
26. Brito JP, Davies L,. Is there really an increased incidence of thyroid cancer? Curr Opin Endocrinol Diabetes Obes. 2014; 21: 405-408.
27. Morris LG, Sikora AG, Tosteson TD, Davies L,. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013; 23: 885-891.
28. Chen AY, Jemal A, Ward EM,. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115: 3801-3807.
29. Malone MK, Zagzag J, Ogilvie JB, Patel KN, Heller KS,. Thyroid cancers detected by imaging are not necessarily small or early stage. Thyroid. 2014; 24: 314-318.
30. Ito Y, Nikiforov YE, Schlumberger M, Vigneri R,. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013; 9: 178-184.